Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies
- PMID: 11206074
- PMCID: PMC2144516
- DOI: 10.1110/ps.9.12.2528
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies
Abstract
The three-dimensional structure of the anti-apoptotic protein Bcl-xL complexed to a 25-residue peptide from the death promoting region of Bad was determined using NMR spectroscopy. Although the overall structure is similar to Bcl-xL bound to a 16-residue peptide from the Bak protein (Sattler et al., 1997), the Bad peptide forms additional interactions with Bcl-xL. However, based upon site-directed mutagenesis experiments, these additional contacts do not account for the increased affinity of the Bad 25-mer for Bcl-xL compared to the Bad 16-mer. Rather, the increased helix propensity of the Bad 25-mer is primarily responsible for its greater affinity for Bcl-xL. Based on this observation, a pair of 16-residue peptides were designed and synthesized that were predicted to have a high helix propensity while maintaining the interactions important for complexation with Bcl-xL. Both peptides showed an increase in helix propensity compared to the wild-type and exhibited an enhanced affinity for Bcl-xL.
Similar articles
-
(alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.J Am Chem Soc. 2007 Jan 10;129(1):139-54. doi: 10.1021/ja0662523. J Am Chem Soc. 2007. PMID: 17199293
-
The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad.Eur J Immunol. 2002 Jul;32(7):1847-55. doi: 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7. Eur J Immunol. 2002. PMID: 12115603
-
Membrane-insertion fragments of Bcl-xL, Bax, and Bid.Biochemistry. 2004 Aug 31;43(34):10930-43. doi: 10.1021/bi036044c. Biochemistry. 2004. PMID: 15323553
-
Bcl-2 family proteins as targets for anticancer drug design.Oncogene. 2000 Dec 27;19(56):6627-31. doi: 10.1038/sj.onc.1204087. Oncogene. 2000. PMID: 11426648 Review.
-
Synthetic peptides and non-peptidic molecules as probes of structure and function of Bcl-2 family proteins and modulators of apoptosis.Apoptosis. 2001 Dec;6(6):453-62. doi: 10.1023/a:1012481406064. Apoptosis. 2001. PMID: 11595835 Review.
Cited by
-
Decoding and unlocking the BCL-2 dependency of cancer cells.Nat Rev Cancer. 2013 Jul;13(7):455-65. doi: 10.1038/nrc3538. Epub 2013 Jun 20. Nat Rev Cancer. 2013. PMID: 23783119 Review.
-
Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells.Mol Endocrinol. 2010 Sep;24(9):1737-47. doi: 10.1210/me.2010-0125. Epub 2010 Jul 21. Mol Endocrinol. 2010. PMID: 20660297 Free PMC article.
-
A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus.J Virol. 2007 Jul;81(13):7178-88. doi: 10.1128/JVI.00404-07. Epub 2007 May 2. J Virol. 2007. PMID: 17475653 Free PMC article.
-
BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins.J Cell Biol. 2007 May 21;177(4):625-36. doi: 10.1083/jcb.200610148. J Cell Biol. 2007. PMID: 17517961 Free PMC article.
-
Targeting the apoptosis pathway in hematologic malignancies.Leuk Lymphoma. 2014 Sep;55(9):1980-92. doi: 10.3109/10428194.2013.855307. Epub 2014 Feb 4. Leuk Lymphoma. 2014. PMID: 24295132 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous